IPI-926

IPI-926 · Infinity Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IPI-926, covering 2012-06-21 to 2017-08-08. Get the full timeline:

Most recent: Clinical Trial Update: FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma [Phase 1]